197 related articles for article (PubMed ID: 29484131)
21. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
[TBL] [Abstract][Full Text] [Related]
22. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
DeWire M; Lazow M; Campagne O; Leach J; Fuller C; Senthil Kumar S; Stanek J; de Blank P; Hummel TR; Pillay-Smiley N; Salloum R; Stevenson CB; Baxter P; Gass D; Goldman S; Leary SES; Carle A; Mikael L; Crabtree D; Chaney B; Lane A; Drissi R; Stewart CF; Fouladi M
Neurooncol Adv; 2022; 4(1):vdac055. PubMed ID: 35611273
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas.
Chen Y; Khan A; Katsinas C; Michniewicz F; Goldberg J; Franshaw L; Tsoli M; Ziegler DS
Neurooncol Adv; 2024; 6(1):vdae029. PubMed ID: 38550394
[TBL] [Abstract][Full Text] [Related]
24. Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.
Chang R; Tosi U; Voronina J; Adeuyan O; Wu LY; Schweitzer ME; Pisapia DJ; Becher OJ; Souweidane MM; Maachani UB
Neurooncol Adv; 2019; 1(1):vdz004. PubMed ID: 32642647
[TBL] [Abstract][Full Text] [Related]
25. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
26. Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma.
Buczkowicz P; Hawkins C
Front Oncol; 2015; 5():147. PubMed ID: 26175967
[TBL] [Abstract][Full Text] [Related]
27. Convection Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: Review of a Single Institution Experience.
Tosi U; Souweidane M
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32674336
[TBL] [Abstract][Full Text] [Related]
28. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
29. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
Jansen MH; van Vuurden DG; Vandertop WP; Kaspers GJ
Cancer Treat Rev; 2012 Feb; 38(1):27-35. PubMed ID: 21764221
[TBL] [Abstract][Full Text] [Related]
30. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
31. STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma.
Park J; Lee W; Yun S; Kim SP; Kim KH; Kim JI; Kim SK; Wang KC; Lee JY
Oncol Lett; 2020 Aug; 20(2):1989-1998. PubMed ID: 32724445
[TBL] [Abstract][Full Text] [Related]
32. New
Plessier A; Le Dret L; Varlet P; Beccaria K; Lacombe J; Mériaux S; Geffroy F; Fiette L; Flamant P; Chrétien F; Blauwblomme T; Puget S; Grill J; Debily MA; Castel D
Oncotarget; 2017 Aug; 8(32):52543-52559. PubMed ID: 28881750
[TBL] [Abstract][Full Text] [Related]
33. REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.
Shaik S; Kennis B; Maegawa S; Schadler K; Yanwen Y; Callegari K; Lulla RR; Goldman S; Nazarian J; Rajaram V; Fangusaro J; Gopalakrishnan V
Oncotarget; 2018 Jan; 9(4):5233-5250. PubMed ID: 29435175
[TBL] [Abstract][Full Text] [Related]
34. ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
Jackson ER; Duchatel RJ; Staudt DE; Persson ML; Mannan A; Yadavilli S; Parackal S; Game S; Chong WC; Jayasekara WSN; Grand ML; Kearney PS; Douglas AM; Findlay IJ; Germon ZP; McEwen HP; Beitaki TS; Patabendige A; Skerrett-Byrne DA; Nixon B; Smith ND; Day B; Manoharan N; Nagabushan S; Hansford JR; Govender D; McCowage GB; Firestein R; Howlett M; Endersby R; Gottardo NG; Alvaro F; Waszak SM; Larsen MR; Colino-Sanguino Y; Valdes-Mora F; Rakotomalala A; Meignan S; Pasquier E; André N; Hulleman E; Eisenstat DD; Vitanza NA; Nazarian J; Koschmann C; Mueller S; Cain JE; Dun MD
Cancer Res; 2023 May; ():OF1-OF17. PubMed ID: 37195023
[TBL] [Abstract][Full Text] [Related]
35. Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies.
Meel MH; Sewing ACP; Waranecki P; Metselaar DS; Wedekind LE; Koster J; van Vuurden DG; Kaspers GJL; Hulleman E
Exp Cell Res; 2017 Nov; 360(2):397-403. PubMed ID: 28947132
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.
Xu C; Liu X; Geng Y; Bai Q; Pan C; Sun Y; Chen X; Yu H; Wu Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Wang Z; Yang R; Lewis J; Bigner D; Zhao F; He Y; Yan H; Shen Q; Zhang L
Oncotarget; 2017 Sep; 8(44):76644-76655. PubMed ID: 29100338
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.
Cockle JV; Brüning-Richardson A; Scott KJ; Thompson J; Kottke T; Morrison E; Ismail A; Carcaboso AM; Rose A; Selby P; Conner J; Picton S; Short S; Vile R; Melcher A; Ilett E
Mol Ther Oncolytics; 2017 Jun; 5():75-86. PubMed ID: 28547002
[TBL] [Abstract][Full Text] [Related]
38. Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.
Caretti V; Jansen MH; van Vuurden DG; Lagerweij T; Bugiani M; Horsman I; Wessels H; van der Valk P; Cloos J; Noske DP; Vandertop WP; Wesseling P; Wurdinger T; Hulleman E; Kaspers GJ
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):426-36. PubMed ID: 22845849
[TBL] [Abstract][Full Text] [Related]
39. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.
Yadavilli S; Scafidi J; Becher OJ; Saratsis AM; Hiner RL; Kambhampati M; Mariarita S; MacDonald TJ; Codispoti KE; Magge SN; Jaiswal JK; Packer RJ; Nazarian J
Oncotarget; 2015 May; 6(14):12141-55. PubMed ID: 25987129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
